These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8487325

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 26. Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.
    Schafer JM, Lee ES, Dardes RC, Bentrem D, O'Regan RM, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2001 Aug; 7(8):2505-12. PubMed ID: 11489833
    [Abstract] [Full Text] [Related]

  • 27. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
    Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK.
    Breast Cancer Res Treat; 1992 Aug; 24(2):85-95. PubMed ID: 8095168
    [Abstract] [Full Text] [Related]

  • 28. Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59).
    Shibata J, Toko T, Saito H, Lykkesfeldt AE, Fujioka A, Sato K, Hashimoto A, Wierzba K, Yamada Y.
    Cancer Chemother Pharmacol; 2000 Aug; 45(2):133-41. PubMed ID: 10663628
    [Abstract] [Full Text] [Related]

  • 29. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [Abstract] [Full Text] [Related]

  • 30. Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.
    Dardes RC, Bentrem D, O'Regan RM, Schafer JM, Jordan VC.
    Clin Cancer Res; 2001 Dec; 7(12):4149-55. PubMed ID: 11751515
    [Abstract] [Full Text] [Related]

  • 31. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP, Jordan VC.
    Cancer Res; 1989 Apr 01; 49(7):1758-62. PubMed ID: 2522347
    [Abstract] [Full Text] [Related]

  • 32. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Apr 01; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 33. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK, Hobbs K, Clark GM.
    Cancer Res; 1985 Feb 01; 45(2):584-90. PubMed ID: 3967234
    [Abstract] [Full Text] [Related]

  • 34. Long-term exposure to tamoxifen induces hypersensitivity to estradiol.
    Berstein LM, Wang JP, Zheng H, Yue W, Conaway M, Santen RJ.
    Clin Cancer Res; 2004 Feb 15; 10(4):1530-4. PubMed ID: 14977857
    [Abstract] [Full Text] [Related]

  • 35. Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.
    Wiebe VJ, Osborne CK, McGuire WL, DeGregorio MW.
    J Clin Oncol; 1992 Jun 15; 10(6):990-4. PubMed ID: 1588380
    [Abstract] [Full Text] [Related]

  • 36. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
    Horii Y, Takei H, Koibuchi Y, Horiguchi J, Maemura M, Iino Y, Morishita Y.
    Oncol Rep; 2006 May 15; 15(5):1191-5. PubMed ID: 16596185
    [Abstract] [Full Text] [Related]

  • 37. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 38. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC, Desta Z, Flockhart DA, Skaar TC.
    Cancer Chemother Pharmacol; 2005 May 01; 55(5):471-8. PubMed ID: 15685451
    [Abstract] [Full Text] [Related]

  • 39. New approaches to the understanding of tamoxifen action and resistance.
    Berstein LM, Zheng H, Yue W, Wang JP, Lykkesfeldt AE, Naftolin F, Harada H, Shanabrough M, Santen RJ.
    Endocr Relat Cancer; 2003 Jun 01; 10(2):267-77. PubMed ID: 12790788
    [Abstract] [Full Text] [Related]

  • 40. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL, Chang CJ, Wang JY, Wen CS, Tseng LM, Chang WC, Noomhorm N, Liu HJ, Chen WS, Chiu JH, Shyr YM.
    Integr Cancer Ther; 2014 May 01; 13(3):226-39. PubMed ID: 24525674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.